Genomic instability in pluripotent stem cells: implications for clinical applications

Area of Science:

• Stem cell biology
• Genomics
• Cell therapy

Background:

• Human pluripotent stem cells (hPSCs) accumulate genomic alterations during proliferation and differentiation.
• These genomic changes raise safety concerns for hPSC-derived cell therapies.
• Current evidence linking hPSC genomic abnormalities to malignancy is limited.

Purpose of the Study:

• To investigate the link between hPSC genomic abnormalities and malignancy.
• To differentiate between innocuous and potentially tumor-causing genomic aberrations in hPSCs.
• To establish safety monitoring protocols for hPSC-derived cell therapies.

Main Methods:

• Review of existing literature on hPSC genomic changes and malignancy.
• Analysis of genomic data from proliferating and differentiating hPSCs.
• Evaluation of high-resolution methods for monitoring genomic stability.

Main Results:

• Genomic abnormalities are acquired by hPSCs during culture.
• A clear link between specific hPSC genomic changes and malignancy is not yet established.
• High-resolution methods like SNP genotyping can detect genomic alterations.

Conclusions:

• Distinguishing between benign and oncogenic genomic aberrations in hPSCs is essential for clinical translation.
• Monitoring hPSCs for genomic stability using methods like SNP genotyping is recommended for cell therapy preparation.
• Further research is needed to fully understand the oncogenic potential of hPSC genomic changes.